H1N1 COUNTERMEASURES STRATEGY AND ... - PHE Home
H1N1 COUNTERMEASURES STRATEGY AND ... - PHE Home
H1N1 COUNTERMEASURES STRATEGY AND ... - PHE Home
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
NBSB Pandemic Influenza Working Group<br />
Detailed Report<br />
11:50-12:10 Passive Antibody as a Therapeutic John Beigel<br />
(Work done at NIAID, NIH, HHS)<br />
12:10-12:30 Oseltamivir Strategy for Unmet <strong>H1N1</strong> Regina Dutkowski<br />
Treatment Needs<br />
12:30-1:00 Panel Discussion Ed Cox<br />
Debra Birnkrant<br />
Fred Hayden<br />
Judith Ng-Cashin<br />
William Sheridan<br />
John Beigel<br />
Elizabeth Higgs<br />
Questions to consider:<br />
What drugs might be available?<br />
Options for use during pandemic?<br />
Can we accelerate the science and clinical trials?<br />
<br />
<br />
Can we accelerate development of other agents?<br />
How do we ensure drugs for severe disease if novel <strong>H1N1</strong>acquires Oseltamivir<br />
(and Peramivir) resistance?<br />
1:00-1:15 Wrap up<br />
1:15 Adjourn<br />
1:30-2:30 Optional Working Lunch Meeting – Consider Next Steps<br />
For more information, please visit our Web site:<br />
www.hhs.gov/aspr/ompsh/nbsb<br />
4
Change language